DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
85.34
+0.83 (0.98%)
May 27, 2025, 3:35 PM - Market open
DexCom Stock Forecast
Stock Price Forecast
According to 18 professional analysts, the 12-month price target for DexCom stock ranges from a low of $82 to a high of $120. The average analyst price target of $98 forecasts a 14.83% increase in the stock price over the next year.
Price Target: $98.00 (+14.83%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 6 | 7 | 7 | 7 | 8 | 8 |
| Hold | 5 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $82 → $102 | Strong Buy | Maintains | $82 → $102 | +19.52% | May 22, 2025 |
| Barclays | Barclays | Hold Maintains $90 → $93 | Hold | Maintains | $90 → $93 | +8.98% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $103 → $106 | Strong Buy | Maintains | $103 → $106 | +24.21% | May 2, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $90 | Buy | Maintains | $100 → $90 | +5.46% | May 2, 2025 |
| Baird | Baird | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +23.04% | May 2, 2025 |
Financial Forecast
Revenue This Year
4.71B
from 4.03B
Increased by 16.66%
Revenue Next Year
5.43B
from 4.71B
Increased by 15.35%
EPS This Year
2.07
from 1.42
Increased by 45.16%
EPS Next Year
2.59
from 2.07
Increased by 25.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.9B | 5.9B | 6.9B | ||
| Avg | 4.7B | 5.4B | 6.2B | ||
| Low | 4.5B | 5.0B | 5.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.5% | 24.8% | 27.0% | ||
| Avg | 16.7% | 15.3% | 14.6% | ||
| Low | 11.0% | 5.6% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.25 | 3.08 | 4.11 | ||
| Avg | 2.07 | 2.59 | 3.19 | ||
| Low | 1.91 | 2.25 | 2.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 57.8% | 48.8% | 58.8% | ||
| Avg | 45.2% | 25.1% | 23.4% | ||
| Low | 34.2% | 9.0% | -1.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.